January 15, 2020
January 14, 2020
Dr. Thomas J. Lynch Jr. named new president and director of Fred Hutch
Dr. Thomas J. Lynch Jr. will become Fred Hutchinson Cancer Research Center’s new president and director, the organization announced today. Lynch, a well-known cancer... Read More
January 13, 2020
Thermo Fisher Scientific Opens $90 Million Viral Vector Manufacturing Site in Massachusetts
Thermo Fisher Scientific Inc., the world leader in serving science, officially opened its new $90 million viral vector CDMO (contract development and manufacturing organization)... Read More
January 13, 2020
Roche and Illumina partner to broaden patient access to genomic testing
Roche has announced that it has entered into a 15-year, non-exclusive partnership with Illumina to broaden the adoption of distributable next-generation sequencing (NGS) based... Read More
December 12, 2019
Michael Rivers, Head of Roche Digital Pathology, named president of Digital Pathology Association
Michael Rivers, Vice President, Roche Digital Pathology, has been named president of the Digital Pathology Association (DPA), effective Jan. 1, 2020. The DPA is... Read More
December 12, 2019
Thermo Fisher Scientific to Bring One-Day Genomic Profiling to Hematology Oncology
Clinical researchers who take a traditional sequential approach to analyze myeloid malignancies, a highly heterogeneous group of disorders, face a major hurdle: a laborious... Read More
November 21, 2019
Bristol-Myers Squib and Pfizer Announce, Controlled Trial to Evaluate the Effect of Atrial Fibrillation Screening on Health Outcomes in Older Individuals
The Bristol-Myers Squibb-Pfizer Alliance today announced the initiation of a new randomized, controlled study, GUARD-AF (ReducinG stroke by screening for UndiAgnosed atRial fibrillation in... Read More
November 21, 2019
Bristol-Myers Squibb Completes Acquisition of Celgene, Creating a Leading Biopharma Company
Bristol-Myers Squibb Company (NYSE:BMY) has announced that it has completed its acquisition of Celgene Corporation (NASDAQ:CELG) following the receipt of regulatory approval from all... Read More
November 21, 2019
Massive Bio and The American Sexual Health Association Partner to Increase Patient Access to Cervical Cancer Clinical Trials
Massive Bio, a leader in Artificial Intelligence (AI) based oncology clinical trial enrollment, and The American Sexual Health Association (ASHA), a leader in advancing... Read More
November 21, 2019
Quality Cancer Care Alliance Network (QCCA) Selects Integra Connect as Preferred Population Health Analytics Partner
Integra Connect, the leading provider of technologies and services for value-based specialty care, today announced it has been selected by the Quality Cancer Care... Read More
November 20, 2019
Thermo Fisher Scientific Introduces First Next-Generation Sequencing Platform That Delivers Specimen to Report in a Single Day
Thermo Fisher Scientific announced the launch of its Ion Torrent Genexus System, the first fully integrated, next-generation sequencing (NGS) platform featuring an automated specimen-to-report... Read More
September 9, 2019
Thermo Fisher Scientific Signs Agreement with Lilly Oncology for Companion Diagnostic to be Used with RET Inhibitor
Thermo Fisher Scientific today announced an agreement with Eli Lilly and Company for development of a companion diagnostic that will use the U.S Food... Read More
September 9, 2019
Cardea Bio and Nanosens Innovations look to combine companies
The Board of Directors of Cardea Bio and the Board of Directors of Nanosens Innovations have each authorized the respective companies to proceed with... Read More
September 3, 2019
Thermo Fisher Scientific Announces Collaboration to Develop Advanced Analytical Workflows for Clinical Laboratories
Thermo Fisher Scientific, the world leader in serving science, and Cedars-Sinai, a leading nonprofit academic healthcare organization, have entered into a collaboration to develop... Read More
September 3, 2019
KPMG, Coriell Life Sciences And Thermo Fisher Scientific To Collaborate On Links Between Medications And Genes
KPMG’s Clinical Intelligence (KCI) platform is helping clinicians improve the quality of care by furnishing them with pharmacogenomics data – information about how genes... Read More
August 15, 2019
CHI Franciscan Activates First AI-Powered Hospital Mission Control Center in Washington State
CHI Franciscan announced the launch of its Mission Control Center, focused on enhancing services, optimizing patient care, and increasing its capacity to serve more... Read More
August 9, 2019
Bayer acquires BlueRock Therapeutics to build leading position in cell therapy
Bayer AG and BlueRock Therapeutics today announced an agreement under which Bayer will fully acquire BlueRock Therapeutics, a privately held US-headquartered biotechnology company focused... Read More
August 9, 2019
Geneia AI-Based Model Improves Personalization and Precision of Health Risk Scores
Geneia, a healthcare analytic solutions and services company that is simplifying the evolution to value-based care, announced today that the Geneia Data Intelligence Lab... Read More
August 9, 2019
MolecularMatch Announces Issuance of US Patent for its Precision Medicine Service
MolecularMatch, a leading clinical informatics company providing Precision Medicine software solutions for oncology, announced today that the United States Patent and Trademark Office has... Read More
August 6, 2019
Genomenon Wins NIH Grant to Develop Micropublications for Genomic Interpretation
Genomenon, Inc., the leading genomic search engine company, announced today that it was awarded a grant by the National Institutes of Health. The Small... Read More
August 2, 2019
Siemens Healthineers, University of Missouri System and University of Missouri Health Care announce formation of new strategic alliance
Siemens Healthineers and the University of Missouri System (UM System), including all four universities, and University of Missouri Health Care (MU Health Care), have... Read More
August 2, 2019
Massive Bio Launches A Hub to Assemble The Largest Artificial Intelligence Enabled Just-In-Time Precision Oncology Clinical Trial Network in The World
Massive Bio, Inc., a leader in precision medicine and artificial intelligence (AI) enabled patient centric clinical trial matching, announces today its newly developed “Hub”... Read More
August 2, 2019
Sema4 Announces Location of its Second Connecticut Lab; Harbor Landing in Stamford Will Soon Be Home to 300+ Employees
Sema4, a patient-centered health intelligence company, announced the location of the company’s second laboratory space in Connecticut for its genomic testing products and digital... Read More
August 2, 2019
Precision for Medicine launches biospecimen solutions offering with acquisition of ProMedDx and GLAS
Precision for Medicine, part of Precision Medicine Group, announced it has acquired leading biospecimen providers ProMedDx and GLAS, significantly expanding its capabilities and expertise... Read More
August 2, 2019
Canadian Government-Sponsored Collaboration Targets Standardized Cancer Testing
Genome Canada, the Ontario Institute for Cancer Research (OICR) and Thermo Fisher Scientific are collaborating to develop a complete solution of targeted next generation... Read More
Tweets
New post: LabCorp to Adopt Thermo Fisher Scientific’s Ion Torrent Genexus Next-Generation Sequencing System and P https://t.co/v7zlccNjyT, - New post: Dr. Thomas J. Lynch Jr. named new president and director of Fred Hutch https://t.co/XSLxmL9sCM,
- New post: Thermo Fisher Scientific Opens $90 Million Viral Vector Manufacturing Site in Massachusetts https://t.co/H3bVYnfVvV,